NCT01838499 - Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa | Biotech Hunter

Enrollment

224

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Hidradenitis Suppurativa

Interventions

BIOLOGICAL

MEDI8968

SC injection at baseline, Week 4 and Week 8

BIOLOGICAL

Saline

SC injection at baseline, Week 4 and Week 8

Trial Locations (27)

Research Site, Phoenix

Research Site, Bakersfield

Research Site, Fremont

Research Site, Los Angeles

Research Site, San Diego

Research Site, San Francisco

Research Site, Miami

Research Site, Orange Park

Research Site, Ormond Beach

Research Site, Tampa

Research Site, Atlanta

Research Site, Macon

Research Site, Skokie

Research Site, West Dundee

Research Site, Evansville

Research Site, Indianapolis

Research Site, Rockville

Research Site, St Louis

Research Site, Forest Hills

Research Site, Chapel Hill

Research Site, High Point

Research Site, Winston-Salem

Research Site, Hershey

Research Site, Philadelphia

Research Site, Rapid City

Research Site, Arlington

Research Site, Norfolk